TABLE 1.
General characteristics of study participants
| Index | Garlic group (N = 47) | Placebo group(N = 51) | p‐value |
|---|---|---|---|
| Age (year) | 46.4 ± 11.3 | 44.1 ± 11.8 | 0.32 |
| Weight (kg) | 82.4 ± 14 | 80.2 ± 15.1 | 0.42 |
| BMI (Kg/m) | 30.7 ± 5.3 | 28.5 ± 6.6 | 0.07 |
| WC (cm) | 95.2 ± 10.7 | 93.7 ± 9.2 | 0.1 |
| Sex | |||
| Male (n %) | 40.4 | 41.1 | 0.94 |
| Female (n %) | 59.6 | 58.9 | |
| NAFLD grade | |||
| Mild (n %) | 29.7 | 45 | 0.29 |
| Moderate (n %) | 61.7 | 49 | |
| Severe (n %) | 8.6 | 6 | |
| SBP (mmHg) | 13.3 ± 1.2 | 13.5 ± 1.2 | 0.5 |
| DBP (mmHg) | 8.9 ± 1.1 | 9.0 ± 0.8 | 0.1 |
| MAP (mmHg) | 10.3 ± 1.0 | 10.4 ± 0.9 | 0.4 |
| Hypertension | |||
| Pre (n %) | 27 | 28 | 0.41 |
| Stage 1 (n %) | 12 | 18 | |
| Stage 2 (n %) | 8 | 5 | |
| Antihypertensive drugs | |||
| Diuretics (n %) | 11 | 17 | 0.58 |
| CCB (n %) | 5 | 4 | |
| ACE inhibitors (n %) | 4 | 2 | |
| Physical activity | |||
| Low | 65.9 | 60.7 | 0.65 |
| Moderate | 25.5 | 33.3 | |
| High | 8.6 | 6 | |
Prehypertension: 80 < DBP < 90 OR 120 < SBP < 140; Stage 1 Hypertension: 90 ≤ DBP < 100 OR 140 ≤ SBP < 160; Stage 2 Hypertension: DBP ≥ 100 OR SBP ≥ 160. Values are expressed as mean ± SD for quantitative variables, and frequency (%) for qualitative variables. p‐values were calculated by Chi‐square test for qualitative variables and Independent‐sample t test for quantitative variables.
Abbreviations: ACE, Angiotensin‐converting enzymeNAFLD, Nonalcoholic fatty liver disease; BMI, Body mass index; CCB, Calcium channel blockers; DBP, Diastolic Blood Pressure; MAP, Mean Arterial Pressure; SBP, Systolic Blood Pressure; WC, Waist Circumference.